BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19457610)

  • 1. Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis.
    Yi CH; Zheng T; Leaderer D; Hoffman A; Zhu Y
    Cancer Lett; 2009 Nov; 284(2):149-56. PubMed ID: 19457610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
    Yi C; Mu L; de la Longrais IA; Sochirca O; Arisio R; Yu H; Hoffman AE; Zhu Y; Katsaro D
    Breast Cancer Res Treat; 2010 Apr; 120(3):663-9. PubMed ID: 19649706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response.
    Hoffman AE; Zheng T; Ba Y; Zhu Y
    Mol Cancer Res; 2008 Sep; 6(9):1461-8. PubMed ID: 18819933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells.
    Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
    Cancer Lett; 2020 Jan; 469():498-509. PubMed ID: 31765736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of NPAS2 in circadian rhythm and disease.
    Peng LU; Bai G; Pang Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Oct; 53(10):1257-1265. PubMed ID: 34415290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear receptor-mediated cell-autonomous oscillatory expression of the circadian transcription factor, neuronal PAS domain protein 2 (NPAS2).
    Matsumura R; Matsubara C; Node K; Takumi T; Akashi M
    J Biol Chem; 2013 Dec; 288(51):36548-53. PubMed ID: 24196956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid-related orphan receptor γ directly regulates neuronal PAS domain protein 2 transcription in vivo.
    Takeda Y; Kang HS; Angers M; Jetten AM
    Nucleic Acids Res; 2011 Jun; 39(11):4769-82. PubMed ID: 21317191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NPAS2: an analog of clock operative in the mammalian forebrain.
    Reick M; Garcia JA; Dudley C; McKnight SL
    Science; 2001 Jul; 293(5529):506-9. PubMed ID: 11441147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A.
    Yuan P; Li J; Zhou F; Huang Q; Zhang J; Guo X; Lyu Z; Zhang H; Xing J
    Cell Death Dis; 2017 Mar; 8(3):e2704. PubMed ID: 28333141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
    Zhu Y; Stevens RG; Leaderer D; Hoffman A; Holford T; Zhang Y; Brown HN; Zheng T
    Breast Cancer Res Treat; 2008 Feb; 107(3):421-5. PubMed ID: 17453337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of Npas2 leads to altered metabolic pathways in a murine knockout model.
    O'Neil D; Mendez-Figueroa H; Mistretta TA; Su C; Lane RH; Aagaard KM
    Mol Genet Metab; 2013 Nov; 110(3):378-87. PubMed ID: 24067359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling.
    Ma S; Chen Y; Quan P; Zhang J; Han S; Wang G; Qi R; Zhang X; Wang F; Yuan J; Yang X; Jia W; Qin W
    BMC Cancer; 2023 Mar; 23(1):280. PubMed ID: 36978001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression.
    Partonen T; Treutlein J; Alpman A; Frank J; Johansson C; Depner M; Aron L; Rietschel M; Wellek S; Soronen P; Paunio T; Koch A; Chen P; Lathrop M; Adolfsson R; Persson ML; Kasper S; Schalling M; Peltonen L; Schumann G
    Ann Med; 2007; 39(3):229-38. PubMed ID: 17457720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-translational regulation of circadian transcriptional CLOCK(NPAS2)/BMAL1 complex by CRYPTOCHROMES.
    Kondratov RV; Kondratova AA; Lee C; Gorbacheva VY; Chernov MV; Antoch MP
    Cell Cycle; 2006 Apr; 5(8):890-5. PubMed ID: 16628007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer.
    Xue X; Liu F; Han Y; Li P; Yuan B; Wang X; Chen Y; Kuang Y; Zhi Q; Zhao H
    Biochem Biophys Res Commun; 2014 Jul; 450(2):1058-62. PubMed ID: 24978311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas.
    Ciribilli Y; Singh P; Spanel R; Inga A; Borlak J
    Oncotarget; 2015 Oct; 6(31):31569-92. PubMed ID: 26427040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
    Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
    Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma.
    Franzoni A; Markova-Car E; Dević-Pavlić S; Jurišić D; Puppin C; Mio C; De Luca M; Petruz G; Damante G; Pavelić SK
    Exp Biol Med (Maywood); 2017 Sep; 242(15):1553-1558. PubMed ID: 28799406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian oscillator NPAS2 regulates diurnal expression and activity of CYP1A2 in mouse liver.
    He Y; Cen H; Guo L; Zhang T; Yang Y; Dong D; Wu B
    Biochem Pharmacol; 2022 Dec; 206():115345. PubMed ID: 36379250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian transcription factor NPAS2 and the NAD
    Becker-Krail DD; Parekh PK; Ketchesin KD; Yamaguchi S; Yoshino J; Hildebrand MA; Dunham B; Ganapathiraju MK; Logan RW; McClung CA
    Eur J Neurosci; 2022 Feb; 55(3):675-693. PubMed ID: 35001440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.